Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAL_Cambodia: Artemether-lumefantrine Prophylaxis for Malaria in Forest Goers
NCT04041973Completed
- Sponsor
- University of Oxford
- Start
- Mar 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of artemether + lumefantrine in malaria (2 arms), sponsored by University of Oxford. Primary endpoint: Composite endpoint of clinical malaria or subclinical infection at 84 days. Started Mar 2020; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04041973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04041973.